Loading
GoHealth, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by KOTTE VIJAY, was filed 15 Nov 2023.
GoHealth, Inc.: what insiders have been doing
GoHealth, Inc., classified in the Healthcare & Pharma sector, is a listed company based in Chicago, United States. Its insiders report their share dealings to SEC (Form 4). Between 23 October 2025 and 23 October 2026, 5 insiders published 6 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Compared with its exchange (278 companies, median 8 filings), a count of 6 filings is below the norm. Looking back to 2020, when coverage begins, insiders filed 93 purchases and 7 sales. The 10-K for the year ended 31 December 2025 shows 361.8 m USD of revenue and -257.1 m USD of net income.
No insider has bought GoHealth, Inc. shares on the open market in the past twelve months. Filings reach the SEC (Form 4) feed a median of 3 days after the trade. The legal deadline for a Form 4 is two business days after the transaction.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Insider Decl.
236
Thresholds
n/a
Buy Volume
€30M
93 ops. · all time
Sell Volume
€6M
7 ops. · all time
Since the insiders bought
- -82.8%Entry US$53.40 · Close at T+365 US$9.17
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate GoHealth, Inc. Buy (bullish), based on 3 analysts. Average price target: US$5.17.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
US$0.31
Analyst consensus
3 analystsBuy
US$1.50Target US$5.17(+1594%)US$10.00
Income statement
RevenueUS$361.8M
Gross profitUS$265.7M73% margin
EBITDA-US$148M-41% margin
Net income-US$261.1M-189.7% margin
Valuation
P/Book2.3x
Beta1.17
Balance sheet & cash
Market capUS$8.9M
Total debtUS$672.6M
Free Cash Flow-US$130.2M
Profitability & ownership
ROE-289.9%
ROA-10.6%
% insiders13.4%
% institutions64.7%
Last declaration on 17 August 2026
Declarations236 total
4,179,850 sharesClass A Common StockSEC:0001104659-26-098011:0
4,179,850 sharesClass A Common StockSEC:0001104659-26-098010:0
157,070 sharesClass A Common StockSEC:0001628280-26-049369:0
1,347,396 sharesClass A Common StockSEC:0001628280-26-049365:0
237,275 sharesClass A Common StockSEC:0001628280-26-049368:0
12,725 shares@ US$3.96100.0% of flowClass A Common StockSEC:0001628280-25-048746:0
5,545 shares@ US$4.987.1% of flowClass A Common StockSEC:0001996571-25-000005:0
218,551 shares0Class A Common StockSEC:0001808220-25-000063:0
814 shares@ US$7.755.9% of flowClass A Common StockSEC:0001808220-25-000041:0
24,612 shares@ US$10.1726.6% of flowClass A Common StockSEC:0001808220-25-000039:0
221,500 shares@ US$11.47Class A Common StockSEC:0001808220-25-000035:1
500,000 shares0Class A Common StockSEC:0001808220-25-000035:0
100,000 shares0Class A Common StockSEC:0001808220-25-000030:1
100,000 shares0Class A Common StockSEC:0001808220-25-000028:1
185,000 shares0Class A Common StockSEC:0001808220-25-000032:1
8,317 shares@ US$12.3928.9% of flowClass A Common StockSEC:0001808220-25-000028:0
24,611 shares@ US$12.3933.8% of flowClass A Common StockSEC:0001808220-25-000032:0
100,000 shares0Class A Common StockSEC:0001808220-25-000026:0
4,884 shares@ US$12.3959.4% of flowClass A Common StockSEC:0001808220-25-000030:0
6,238 shares@ US$13.0022.6% of flowClass A Common StockSEC:0001808220-25-000019:0
1,099 shares@ US$13.0013.9% of flowClass A Common StockSEC:0001808220-25-000021:0
150,000 shares0Class A Common StockSEC:0001808220-24-000122:0
5,545 shares@ US$8.2812.5% of flowClass A Common StockSEC:0001808220-24-000110:0
4,159 shares@ US$9.0810.5% of flowClass A Common StockSEC:0001808220-24-000105:0
14,605 shares@ US$10.2749.9% of flowClass A Common StockSEC:0001808220-24-000091:0
25 of 236 declarations
About GoHealth, Inc.
GoHealth, Inc. (ticker: GOCO) is a U.S.-listed company trading on the NASDAQ in the United States. For international investors, GoHealth is best understood as a healthcare distribution and insurance marketplace platform with a strong Medicare focus. The company was founded in 2001 by Clint Jones and Brandon Cruz, initially as a comparison site for insurance carriers. Over time, it expanded into lead generation, enrollment, and consumer matching capabilities, evolving into an integrated digital insurance marketplace. GoHealth’s corporate headquarters are in Chicago, Illinois.
The company’s core business centers on a proprietary technology platform that combines machine-learning algorithms, more than two decades of insurance purchasing behavior, and licensed human agents. This hybrid model is designed to help consumers find health plans that fit their individual needs, particularly within Medicare. GoHealth positions itself as a consumer-first marketplace, emphasizing plan suitability, enrollment quality, and renewal economics rather than a purely transactional sales model. Historically, the company was also active in Affordable Care Act enrollment, but its strategic center of gravity has shifted toward Medicare in recent years.
Read moreShow less
From a competitive standpoint, GoHealth operates in a fragmented but highly competitive environment that includes insurance brokers, digital enrollment platforms, lead-generation businesses, and insurers with their own distribution channels. Its relative advantage lies in the combination of proprietary technology, licensed sales support, and the ability to process large enrollment volumes. Management continues to focus on improving conversion efficiency, strengthening back-book economics, and refining consumer matching. The company does not pay dividends and instead reinvests in its technology stack, licensed agent force, and the Encompass platform.
Recent developments suggest a company in strategic transition. In its latest disclosures and earnings communications, GoHealth has emphasized cash discipline, portfolio durability, and a more selective stance on Medicare Advantage, while maintaining leadership in Special Needs Plans (SNP). A notable strategic step was the 2025 launch of GoHealth Protect, an expansion beyond Medicare-related products into life insurance designed to address end-of-life and broader financial protection needs. The company is also investing in AI and operational efficiency, while management has indicated that consolidation opportunities remain part of its long-term strategic framework in a still-fragmented industry.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
